UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000045633
Receipt No. R000052094
Scientific Title Research on newborn screening for treatable neonatal and childhood diseases
Date of disclosure of the study information 2022/01/01
Last modified on 2022/04/01 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Research on newborn screening for treatable neonatal and childhood diseases
Acronym Research on expanded newborn screening
Scientific Title Research on newborn screening for treatable neonatal and childhood diseases
Scientific Title:Acronym Research on expanded newborn screening
Region
Japan

Condition
Condition primary immunodeficiency, spinal muscular atrophy
Classification by specialty
Obsterics and gynecology Pediatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We aim for early diagnosis and treatment by performing newborn screening for primary immunodeficiency and spinal muscular atrophy using dried blood spots.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes establishment of implementation system (1 year from the start)
Key secondary outcomes evaluation of efficacy (epidemiological survey in 10 years)

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Other
Interventions/Control_1 screening for primary immunodeficiency and spinal muscular atrophy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
1 months-old >=
Gender Male and Female
Key inclusion criteria newborns undergoing current newborn screening
Key exclusion criteria consent not available
Target sample size 5000

Research contact person
Name of lead principal investigator
1st name Kohsuke
Middle name
Last name Imai
Organization Tokyo Medical and Dental University
Division name Pediatrics
Zip code 113-8519
Address 1-5-45, Yushima, Bunkyo, Tokyo
TEL 0338136111
Email kimai.ped@tmd.ac.jp

Public contact
Name of contact person
1st name Tomoko
Middle name
Last name Mizuno
Organization Tokyo Medical and Dental University
Division name Pediatrics
Zip code 1138519
Address 1-5-45, Yushima, Bunkyo, Tokyo
TEL 0338136111
Homepage URL
Email tmizuno.ped@tmd.ac.jp

Sponsor
Institute Tokyo Medical and Dental University
Institute
Department

Funding Source
Organization AMED
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The department of general affairs, Tokyo Medical and Dental University
Address 1-5-45, Yushima, Bunkyo, Tokyo
Tel 03-5803-5096
Email syomu1.adm@tmd.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 01 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 0
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2021 Year 09 Month 01 Day
Date of IRB
2021 Year 11 Month 05 Day
Anticipated trial start date
2022 Year 01 Month 01 Day
Last follow-up date
2032 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 10 Month 01 Day
Last modified on
2022 Year 04 Month 01 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052094